20 B future market but a lot of competition is developing and ABT, INCY/LLY, PFE, RIGL/AZN are going to compete in this market.
Lets see how much is the ACR 20? Results have to be North of 50 to be remain in the game. Partner usually offers
VRTX is doing a poster presentation in EULAR 06/13/2013 where VX 509 data and biomarker will be presented. Basic but we have some representation and I am sure this will be attracting researchers attention working for big biopharma like AMGN, GILD and others.